Codes / ICD10CM / E75.5

E75.5 Other lipid storage disorders

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Lipid Storage Disorders (ICD-10 Code: E75.5)

Summary

Other lipid storage disorders are a group of inherited conditions characterized by the abnormal accumulation of lipids in cells, disrupting normal cellular function. These disorders affect multiple organ systems, including the nervous system, liver, and spleen. The severity and specific manifestations vary depending on the type of lipid storage disorder.

Causes

These disorders are caused by genetic mutations that impair the function of enzymes or proteins involved in lipid metabolism. The mutations lead to the buildup of specific lipids in tissues. Inherited in an autosomal recessive or, less commonly, autosomal dominant pattern, the conditions result from defects in genes responsible for lipid breakdown or transport.

Risk Factors

  • Family history of lipid storage disorders.
  • Consanguineous relationships (increased risk of recessive inheritance).
  • Ethnic backgrounds with higher prevalence of specific disorders.

Symptoms

  • Neurological symptoms, including developmental delay, seizures, or motor dysfunction.
  • Organ enlargement (e.g., hepatosplenomegaly).
  • Skin abnormalities, such as xanthomas or ichthyosis.
  • Gastrointestinal issues, including abdominal pain or malabsorption.
  • Respiratory complications in severe cases.

Diagnosis

Diagnosis involves a combination of clinical evaluation, family history assessment, and laboratory tests. Enzyme assays, genetic testing, and imaging studies (e.g., MRI) may be used to identify lipid accumulation. Biopsy of affected tissues (e.g., liver or skin) can confirm the diagnosis by showing lipid deposits.

Treatment Options

Treatment is supportive and symptomatic, focusing on managing complications. Enzyme replacement therapy may be available for some subtypes. Physical therapy, occupational therapy, and nutritional support are often recommended. In severe cases, organ transplantation (e.g., liver or bone marrow) may be considered.

Prognosis and Follow-Up

Prognosis varies widely depending on the specific disorder and its severity. Early diagnosis and intervention can improve outcomes. Regular follow-up with specialists (e.g., neurologists, geneticists) is essential to monitor organ function and adjust treatment plans as needed.

Complications

  • Progressive neurological decline.
  • Organ failure (e.g., liver or spleen dysfunction).
  • Respiratory insufficiency.
  • Developmental delays or regression.
  • Increased risk of infections due to immune system involvement.

Lifestyle & Prevention

  • Genetic counseling for families with a history of lipid storage disorders.
  • Prenatal testing or carrier screening for at-risk individuals.
  • Maintaining a balanced diet to support overall health.
  • Avoiding medications that may exacerbate lipid accumulation (consult healthcare providers).

When to Seek Professional Help

Seek medical attention if symptoms such as developmental delays, seizures, or unexplained organ enlargement occur. Prompt evaluation is critical for early diagnosis and management.

Tips for Medical Coders

Document the specific subtype of lipid storage disorder when available, as E75.5 is a broad category. Include details about clinical manifestations, genetic testing results, or biopsy findings to support coding accuracy. Ensure documentation aligns with the ICD-10-CM guidelines for "other specified" conditions.

Medical Policies and Guidelines

Related policies from health plans

Kanuma (sebelipase alfa)
Book a walkthrough

E75.5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.